Cancer-related cognitive impairment (CRCI), often referred to as "chemobrain," is a common and distressing consequence of cancer treatment, affecting memory, attention, and executive functioning. For aging cancer survivors, CRCI may compound existing age-related cognitive vulnerabilities, potentially increasing the risk for long-term cognitive decline and dementia. This presentation explores how physical activity, particularly aerobic, resistance, and mind-body exercise, alongside cognitive training, dual-task training, and exergaming, can mitigate CRCI and support cognitive resilience. Participants will learn about the biological mechanisms linking exercise and cognitive health, the evidence supporting multimodal interventions, and practical approaches for integrating these strategies into survivorship and geriatric care.
You will find the link for the live ZOOM session under the course in your Kajabi account. Following the masterclass, you will then find the recording there as well.
What you'll get:
- Live Zoom Access on July 23, 9-9:30am Pacific
- Lifetime access to the recorded session.
Ryan Glatt is a cognitive health specialist and Senior Brain Health Coach at the Pacific Neuroscience Institute. Currently pursuing his PhD, Ryan combines his expertise in exercise science (MES) and board certification in health and wellness coaching (NBC-HWC) to develop evidence-based strategies for enhancing brain health and cognitive function.
With over a decade of experience in health coaching, neurorehabilitation, and applied neuroscience, Ryan works collaboratively with clinicians, researchers, and patients to translate the latest neuroscience findings into practical interventions. He specializes in integrative approaches that include physical activity, cognitive training, stress management, and lifestyle modification to support individuals across the cognitive health spectrum—from peak performance to neurodegenerative conditions.
Ryan is also a sought-after speaker and educator in the fields of brain health and behavior change, and is deeply committed to advancing personalized, preventative neuroscience through both clinical practice and research.